Infectious Diseases

< Back

Overview

The aim of the seven groups of this area is to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group is mainly focused on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new preventive vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. Microbiology studies mechanisms of resistance to antimicrobials, pathogenicity, taxonomy and epidemiology, and infectious diseases diagnostics.

The CRIPS group focuses on the most prevalent aspects of infections in the intensive care unit (ICU), while SODIR group works in the areas of shock, organ dysfunction and resuscitation.

There is also a group focused on infection in immunocompromised pediatric patients, and a group from the CIBBIM-Nanomedicine interested in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of medicine.

Publications

108
total
876.949
impact factor
4.665
average impact factor

Group Leader: Jordi Rello

Publications achieved high visibility, with near 3,000 new citations . The group has been awarded as “Grup de Recerca Consolidat” by AGAUR. Several SR & MA in respiratory infections have been registered (PROSPERO). Activities from ICP of Pneumonia at CIBERES have been awarded with excellence by the SAB, contributing to ESCMID Clinical Practice Guidelines. The Top Ten Multi-resistant organisms in Critically Ill (TOTEM project) were identified, using MCDA methodology. Different epidemiological studies on ventilatory-associated events were launched, enclosing a multicenter study in children. Also, different research projects on immuno-phenotyopes, biomarkers and epidemiology of influenza have been started. We expanded research activities as part of the Nine-i investigators network. An educational ERS module on respiratory infections has been released. Important support was provided to RCT, participating in advisory boards and DMC committees.

VHIR Annual Report 2018